Vermillion Wealth Management’s bluebird bio BLUE Stock Holding History

Vermillion Wealth Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-114	Closed	-$556	–	541
2025 Q1	$556	Hold	114	–	–	﹤0.01%	1250
2024 Q4	$951	Buy	+114	New	+$996	﹤0.01%	488

Other funds holding BLUE

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vermillion Wealth Management's BLUE Position: Q2 2025 in Review

Vermillion Wealth Management sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 114 shares — an estimated $556 sold.

Vermillion Wealth Management first reported a position in BLUE in Q4 2024 and held it in 2 quarters. The position peaked at $951 in Q4 2024. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Vermillion Wealth Management reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Vermillion Wealth Management sold 114 bluebird bio shares in Q2 2025, an estimated $556.
Vermillion Wealth Management first reported a position in bluebird bio in Q4 2024 and held it in 2 quarters.
Vermillion Wealth Management's bluebird bio position peaked at $951 in Q4 2024.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Vermillion Wealth Management's 13F filing for Q2 2025, filed 17 Jul 2025.